Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This phase IIa study is designed as a multi-centre, multinational, randomised, double-blind,
placebo controlled study in three parallel groups, with the aim to evaluate the efficacy and
safety of Nepadutant given at two oral doses once daily for seven days in comparison to
placebo in the treatment of infantile colic.